- HK$8.77bn
- HK$11.44bn
- HK$5.77bn
- 59
- 79
- 22
- 56
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 7.26 | ||
| PEG Ratio (f) | 0.77 | ||
| EPS Growth (f) | 10.4% | ||
| Dividend Yield (f) | 6.16% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.23 | ||
| Price to Tang. Book | 1.49 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.54 | ||
| EV to EBITDA | 6.38 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 12.46% | ||
| Return on Equity | 15% | ||
| Operating Margin | 23.27% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | HK$m | 4,260.9 | 5,356.76 | 6,434.02 | 6,463.01 | 5,773.25 | 6,480.45 | 7,227.87 | 4.49% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -40.34 | +29.17 | +45.49 | +18.15 | -17.96 | +8.92 | +13.32 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
SSY Group Ltd, formerly known as Lijun International Pharmaceutical Holding Co Ltd, is an investment holding company principally engaged in the research, development, manufacture and sale of pharmaceutical products. The Company’s main products include finished medicines of mainly intravenous infusion solution to hospitals and distributors, bulk pharmaceuticals and medical materials. The Company’s products mainly include non-PVC (Polyvinyl chloride) soft bag infusion solution, PP (Polypropylene) plastic bottle infusion solution and Glass bottle infusion solution. The Company’s products also include Hydrochloride Betahistine, Hydrochloride Ambroxol and Doxofylline as well as bulk pharmaceuticals including caffeine, theophylline, aminophylline, metronidazole and nifedipine.
Directors
- Jiguang Qu CHM (66)
- Hing Yeung Chow CFO (42)
- Guo Meng EDR (47)
- Xuejun Su EDR (53)
- Hao Feng NED (40)
- Kwok Wai Chow NID (54)
- Chong Shun Leung NID (55)
- Yibing Wang NID (58)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- September 28th, 2004
- Public Since
- December 20th, 2005
- No. of Employees
- 6,100
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Stock Exchange of Hong Kong Limited- Shares in Issue
- 2,953,913,385
- Address
- Rooms 4902-03, 49th Floor, Central Plaza
- Web
- https://www.ssygroup.com.hk/
- Phone
- +852 null26880869
- Contact
- Hing Yeung Chow
- Auditors
- KPMG
Upcoming Events for 2005
SSY Group Ltd Annual Shareholders Meeting
Dividend For 2005.HK - 0.0950 HKD
Half Year 2025 SSY Group Ltd Earnings Release
Similar to 2005
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
AIM Vaccine Co
Stock Exchange of Hong Kong Limited
Ascletis Pharma
Stock Exchange of Hong Kong Limited
Asymchem Laboratories Tianjin Co
Stock Exchange of Hong Kong Limited
FAQ
What is the SSY share price?
As of Today at 23:25 UTC, shares in SSY are trading at HK$3.01. This share price information is delayed by 15 minutes.
How has the SSY share price performed this year?
Shares in SSY last closed at HK$3.01 and the price had moved by -36.5% over the past 365 days. In terms of relative price strength the SSY share price has underperformed the FTSE Developed Asia Pacific Index by -35.77% over the past year.
What are the analyst and broker recommendations for SSY?
The overall consensus recommendation for SSY is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the SSY dividend yield?
The SSY dividend yield is 5.81% based on the trailing twelve month period.
Does SSY pay a dividend?
Last year, SSY paid a total dividend of HK$0.18, and it currently has a trailing dividend yield of 5.81%.Looking ahead, shares in SSY are due to go ex-dividend on 2025-05-20 and the next dividend pay date is 2025-06-03.
When does SSY next pay dividends?
SSY are due to go ex-dividend on 2025-05-20 and the next dividend pay date is 2025-06-03. The historic dividend yield on SSY shares is currently 5.81%.
How do I buy SSY shares?
To buy shares in SSY you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of SSY?
As of the previous close price of HK$3.01, shares in SSY had a market capitalisation of HK$8.77bn.
Where are SSY shares listed?
Here are the trading details for SSY:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 2005
What kind of share is SSY?
Based on an overall assessment of its quality, value and momentum SSY is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a SSY share price forecast for 2025?
The analyst consensus target price for shares in SSY is HK$5.16. That is 71.45% above the last closing price of HK$3.01.
Analysts covering SSY currently have a consensus Earnings Per Share (EPS) forecast of HK$0.40 for the next financial year.
Find out moreWhat is the trend in the SSY share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like SSY. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -16.72%.
As of the last closing price of HK$3.01, shares in SSY were trading -16.71% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the SSY PE Ratio?
The SSY PE ratio based on its reported earnings over the past 12 months is 7.26. The shares last closed at HK$3.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of SSY?
SSY's management team is headed by:
- Jiguang Qu - CHM
- Hing Yeung Chow - CFO
- Guo Meng - EDR
- Xuejun Su - EDR
- Hao Feng - NED
- Kwok Wai Chow - NID
- Chong Shun Leung - NID
- Yibing Wang - NID